LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sona Nanotech Inc. (Sona or the Company) (OTC: SNANF) for violations of the securities laws.<\/p>\n
The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Sona announced on October 29, 2020, that the FDA had denied its request for an emergency use authorization to market its rapid COVID-19 antigen test in the United States. The Companys shares fell 48% on the same day. Then on November 25, 2020, the Company announced the withdrawal of an Interim Order authorization from Health Canada for the marketing of its rapid, COVID-19 antigen test in order to obtain more clinical data to augment its submission. Based on this news, shares of Sona fell by more than 67% on the same day.<\/p>\n
If you are a shareholder who suffered a loss, click here to participate.<\/p>\n
We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at http:\/\/www.schallfirm.com<\/a>, or by email at brian@schallfirm.com<\/a>.<\/p>\n The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.<\/p>\n This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n<\/p>\n <\/p>\n Continue reading here:<\/p>\n INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Sona Nanotech Inc. and Encourages Investors with Losses of...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sona Nanotech Inc. Continue reading